Companies know exactly what they spend on research, but knowing exactly what they get for their money is a more difficult question to answer. Without a good way to measure value, research can be viewed as a cost that can be cut to boost near-term earnings. The number of patents is one metric for measuring the value of research, but that information is not necessarily useful without knowing the business value of those patents in the marketplace. What other metrics serve to highlight the value of research and innovation? On June 27 and 28, 2017, the Government-University-Industry Research Roundtable held a meeting to explore these issues. This publication briefly summarizes the presentations and discussions from the meeting.
http://ift.tt/2zfNsL3
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
Ετικέτες
Δευτέρα 16 Οκτωβρίου 2017
Beyond Patents: Assessing the Value and Impact of Research Investments: Proceedings of a Workshop–in Brief.
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Summary Insulinomas are rare neuroendocrine tumours that classically present with fasting hypoglycaemia. This case report discusses an un...
-
The online platform for Taylor & Francis Online content New for Canadian Journal of Remote Sen...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου